Navigating the New Landscape of UK R&D Tax Relief: What Businesses Need to Know

The UK government’s research and development tax relief scheme is undergoing a significant shift, with businesses now required to take a proactive approach rather than a retrospective one. The newly merged R&D expenditure credit scheme, along with guidance from HM Revenue & Customs, is changing the game for businesses seeking tax relief.

Under the new guidelines, businesses must think ahead and gather detailed evidence of their R&D projects during planning stages. Failure to do so could result in claims being reviewed and rejected, leading to potential penalties and even discovery powers being invoked by HMRC.

One of the key changes is the introduction of the Enhanced R&D Intensive Support (ERIS) for loss-making SMEs that meet a threshold for R&D intensity. This could have a significant impact on the finances of eligible businesses, making it crucial for them to factor in the potential return from the relief when planning investments.

Supply chain relationships are also under scrutiny, with the merged scheme defining which entity can claim tax relief for contracted out R&D activities. This could result in winners and losers, particularly for large businesses that have never had to navigate this issue before.

Portfolio managers, including private equity and venture capital investors, will need to closely monitor trends in claim value and inquiry rate to inform their investment strategy based on risk appetite. The increased compliance checks and decreased rates of relief could push businesses towards alternative incentives such as direct grant funding.

Overall, businesses of all sizes and sectors need to consider visibility, protection, and integration when it comes to navigating the new R&D tax relief landscape. Understanding where R&D is taking place, protecting against risks, and integrating incentives into a comprehensive strategy will be key to maximizing benefits in this evolving environment.